These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. MacGlashan DW; Peters SP; Warner J; Lichtenstein LM J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427 [TBL] [Abstract][Full Text] [Related]
24. Nonessential role of leukotrienes as mediators of acute gastric mucosal injury induced by aspirin in rats. Lee M; Feldman M Dig Dis Sci; 1992 Aug; 37(8):1282-7. PubMed ID: 1499454 [TBL] [Abstract][Full Text] [Related]
25. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle. Jonsson EW Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121 [TBL] [Abstract][Full Text] [Related]
26. Leukotriene D4 receptors are not negatively coupled to adenylyl cyclase in guinea-pig lung parenchyma. Giembycz MA; Diamond J; Rodger IW Br J Pharmacol; 1993 Mar; 108(3):824-32. PubMed ID: 8385538 [TBL] [Abstract][Full Text] [Related]
27. Effect of FLAP antagonist MK-0591 on leukotriene production and ozone-induced airway responses in dogs. Stevens WH; Lane CG; Woolley MJ; Ellis R; Tagari P; Black C; Ford-Hutchinson A; O'Byrne PM J Appl Physiol (1985); 1994 Apr; 76(4):1583-8. PubMed ID: 8045835 [TBL] [Abstract][Full Text] [Related]
28. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4). Surette ME; Krump E; Picard S; Borgeat P Mol Pharmacol; 1999 Nov; 56(5):1055-62. PubMed ID: 10531413 [TBL] [Abstract][Full Text] [Related]
29. Chronic leukotriene inhibition in the rat fails to modify the toxicological effects of a cyclooxygenase inhibitor. Ford-Hutchinson AW; Tagari P; Ching SV; Anderson CA; Coleman JB; Peter CP Can J Physiol Pharmacol; 1993; 71(10-11):806-10. PubMed ID: 8143238 [TBL] [Abstract][Full Text] [Related]
30. A new class of leukotriene biosynthesis inhibitor: the development of MK-0591. Prasit P; Belley M; Blouin M; Brideau C; Chan C; Charleson S; Evans JF; Frenette R; Gauthier JY; Guay J J Lipid Mediat; 1993; 6(1-3):239-44. PubMed ID: 8357985 [TBL] [Abstract][Full Text] [Related]
31. BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokinetics. Müller-Peddinghaus R; Fruchtmann R; Ahr HJ; Beckermann B; Bühner K; Fugmann B; Junge B; Matzke M; Kohlsdorfer C; Raddatz S J Lipid Mediat; 1993; 6(1-3):245-8. PubMed ID: 8395246 [TBL] [Abstract][Full Text] [Related]
32. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736 [TBL] [Abstract][Full Text] [Related]
33. Effects of COX-1 and COX-2 inhibitors on eicosanoid biosynthesis and the release of substance P from the guinea-pig isolated perfused lung. Amann R; Schuligoi R; Peskar BA Inflamm Res; 2001 Jan; 50(1):50-3. PubMed ID: 11235022 [TBL] [Abstract][Full Text] [Related]
34. Effect of calcium antagonists on the biosynthesis and contractile effects of peptidoleukotrienes in rhesus monkey lung. Weichman BM; Muccitelli RM; Tucker SS; DeVan JF J Pharmacol Exp Ther; 1985 May; 233(2):345-51. PubMed ID: 3999025 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological modulation of activation-secretion of rat serosal mast cells by chymase, an endogenous secretory granule protease. Schick B; Austen KF Immunology; 1985 Nov; 56(3):513-22. PubMed ID: 3935569 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the anti-inflammatory effect of FK-506 on human mast cells. de Paulis A; Cirillo R; Ciccarelli A; de Crescenzo G; Oriente A; Marone G J Immunol; 1991 Dec; 147(12):4278-85. PubMed ID: 1721644 [TBL] [Abstract][Full Text] [Related]
37. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors. Evans JF; Lévillé C; Mancini JA; Prasit P; Thérien M; Zamboni R; Gauthier JY; Fortin R; Charleson P; MacIntyre DE Mol Pharmacol; 1991 Jul; 40(1):22-7. PubMed ID: 1857337 [TBL] [Abstract][Full Text] [Related]
38. Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchyma. Sakata K; Bäck M Eur J Pharmacol; 2002 Feb; 436(1-2):119-26. PubMed ID: 11834255 [TBL] [Abstract][Full Text] [Related]
39. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart. Hu WM; Man RY Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604 [TBL] [Abstract][Full Text] [Related]
40. The 5-lipoxygenase inhibitors ZD2138 and ZM230487 are potent and selective inhibitors of several antigen-induced guinea-pig pulmonary responses. Kusner EJ; Buckner CK; Dea DM; DeHaas CJ; Marks RL; Krell RD Eur J Pharmacol; 1994 May; 257(3):285-92. PubMed ID: 7522174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]